Open Access
Subscription or Fee Access
MEDICO-LEGAL ASPECTS OF MOLECULA R MEDICINE
Abstract
The prevalence of cancer in the emergingcountries
is higher than in developed countries.
Mortality from cancer in emerging countries is
currently at 2.5 million and is predicted to rise to
6.5 million by the year 201 5 (W.H.O.). More than
50% of the world's cancer load is in the emerging
countries.
Cancer accounts for 20% of all deaths at KNH.
This rises to 40% in the older age groups. The
overall cancer burden is now increasing due to the
HIVIAIDS phenomenon. This means there will be
an increase in demand for cancer services in the
next 10-15 years. The social costs of early deaths
to care-givers and family income earners also
make it prudent to invest in cancer services.
is higher than in developed countries.
Mortality from cancer in emerging countries is
currently at 2.5 million and is predicted to rise to
6.5 million by the year 201 5 (W.H.O.). More than
50% of the world's cancer load is in the emerging
countries.
Cancer accounts for 20% of all deaths at KNH.
This rises to 40% in the older age groups. The
overall cancer burden is now increasing due to the
HIVIAIDS phenomenon. This means there will be
an increase in demand for cancer services in the
next 10-15 years. The social costs of early deaths
to care-givers and family income earners also
make it prudent to invest in cancer services.
Refbacks
- There are currently no refbacks.
